Giant cell arteritis

Clinical and Experimental Optometry

Volumn 85, Issue 1, 2002, Pages 19-26

  Gurwood, Andrew S ^a   Malloy, Kelly A ^a  

^a The Eye Institute   (United States)

Author keywords

Arteritic ischaemic optic neuropathy; Giant cell arteritis; Non arteritic ischaemic optic neuropathy; Optic neuritis; Posterior ischaemic optic neuropathy; Retrobulbar optic neuritis

Indexed keywords

HUMAN; ISCHEMIC OPTIC NEUROPATHY; OPTIC NEURITIS; REVIEW; TEMPORAL ARTERITIS;

HUMANS; OPTIC NEURITIS; OPTIC NEUROPATHY, ISCHEMIC; TEMPORAL ARTERITIS;

EID: 0036366931     PISSN: 08164622     EISSN: 14440938     Source Type: Journal    
DOI: 10.1111/j.1444-0938.2002.tb03068.x     Document Type: Review

References (53)

1. Glaser JS, Topical diagnosis: prechiasmal visual pathways. In: Glaser JS, ed. Neuroophthalmology, 2nd ed. Philadelphia: JB Lippincott Co, 1990: 83-170.
2. Jacobs DS, Foster CS. Temporal arteritis. In: Roy F. The Eye in Systemic Disease. Philadelphia: Mosby, 1994: 100-115.
3. Sandier NA, Ziccardi V, Ochs M. Differential diagnosis of jaw pain in the elderly. J Am Dent Assoc 1995;126:1263-1272.
4. Gonzalez EB, Arteritis associated with systemic disease. Coron Artery Dis 1995; 6: 207-212.
5. Goldstein LJ, Temporal arteritis. Ann Vasc Surg 1995;9:129-133.
6. Matteson EL, Gold KN, Bloch DA, Hunder GG. Long term survival with giant cell arteritis in the American College of Rheumatology Giant Cell Arteritis Classification Criteria Cohort. Am J Med 1996; 100:193-196.
7. Chittenden HB, Clearkin LG, Sidky K. Herpes zoster ophthalmicus masquerading as giant cell arteritis. Br J Hosp Med 1995;54:49-50.
8. AbuRrahma AF, Thaxton L. Temporal arteritis: diagnostic and therapeutic considerations. Am Surg 1996;62:449-451.
9. McLeod D, Kohner EM. Cotton-wool spots and giant cell arteritis. Ophthalmology 1996;103:701-702.
10. Fest T, Mougin C, Dupond JL. Giant cell arteritis. Ann Intern Med 1996;124:927-928.
11. Costa MM, Romeu JC, da-Silva P, de-Queiroz V. Successful treatment of ischemic optic neuropathy secondary to giant cell arteritis with intravenous pulse of methylprednisone. Clin Rheumatol 1995;14:713-714.
12. Nordborg E, Nordberg C, Malmvall BE, Anderson R, Bengtsson BA. Giant cell arteritis. Rheum Dis Clin North Am 1995;21:1013-1026.
13. Gonzalez-Gay MA. The quest for the ideal therapy for giant cell arteritis. Rev Rheum Engl Ed 1995;62:539.
14. Rauser M, Rismondo V. Ischemic optic neuropathy during corticosteroid therapy for giant cell arteritis. Arch Ophthalmol 1995;113:707-708.
15. Wolin MJ, Kent AD. Persisting temporal arteritis. Ophthalmology 1995;102:701.
16. Barland P, Lipstein E. Selection and use of laboratory tests in the rheumatic diseases. Am J Med 1996;100:16s-23s.
17. Stevens RJ, Hughs RA. The aetiopathogenisis of giant cell arteritis. Br J Rheumatol. 1995;34:960-965.
18. Bergman MJ, Collagen-vascular disease. In: Muchnick BG, ed. Clinical Medicine in Op tome trie Practice. Philadelphia: Mosby, 1994: 129-140.
19. Pagani JM, Laboratory tests. In: Blaustein BH. Ocular Manifestations of Systemic Disease. New York: Churchill Livingston, 1994: 1-15.
20. Alexander LJ, Congenital and acquired anomalies of the optic nerve head. In: Alexander LJ. Primary Care of The Posterior Segment, 2nd ed. East Norwalk: Appleton and Lange, 1994: 89-170.
21. Keltener JL, Giant cell arteritis signs and symptoms. Ophthalmology 1982;89:1101-1110.
22. Litwak AB, Optic disc edema. In: Blaustein BH, ed. Ocular Manifestations of Neurologic Disease. Philadelphia: Mosby, 1996: 153-174.
23. Hayreh SS, Podhajsky PA, Raman R, Zimmerman B. Giant cell arteritis: validity and reliability of various diagnostic criteria. Am J Ophthalmol 1997;123:285-296.
24. Gurwood AS, Brilliant R, Malloy KA. The enigma of giant cell arteritis: multidisciplinary management of two cases. J Am Optom Assoc 1998;69:501-509.
25. Caselli RJ, Hunder GG. Neurologic aspects of giant cell (temporal) arteritis. Rheum Dis Clin North Am 1993;19:941-953.
26. Clearkin L, Caballero J. Recovery of visual function in anterior ischemic optic neuropathy due to giant cell arteritis. Am J Med 1992;92:703-704.
27. Danesh-Meyer HV. Savino PJ, Sergott RC. The prevalence of cupping in end-stage arteritic and nonarteritic anterior ischemic optic neuropathy. Ophthalmology 2001;108:593-598.
28. Gaynes BI, Occult giant cell arteritis: a diagnosis of suspicion. J Am Optom Assoc 1994;65:564-571.
29. Hayreh SS, Podhajsky PA, Zimmerman B. Occult giant cell arteritis: ocular manifestations. Am J Ophthalmol 1998;125:521-526. (Pubitemid 28236920)
30. Liu GT, Glaser JS, Schatz NJ, Smith JL. Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision. Ophthalmology 1994;101:1779-1785.
31. McFadzean RM, Ischemic optic neuropathy and giant cell arteritis. Curr Opin Ophthalmol 1998;9:10-17.
32. Tovilla-Canales JL. Ocular manifestations of giant cell arteritis. Curr Opin Ophthalmol 1998;9:73-79.
33. Gur H, Ehrenfeld M, Izsak E. Pleural effusion as a presenting manifestation of giant cell arteritis. Clin Rheumatol 1996;15:200-203.
34. Lesser AS, Aledort D, Lie JT. Non-giant cell arteritis of the temporal artery presenting as the polymyalgia rheumatica-temporal arteritis syndrome. J Rheumatol 1995;22:2177-2182.
35. van der Veen MJ. Dinant HJ, van Booma-Frankfort C, van Albada-Kuipers GA, Bijlsma JWJ. Can methotrexate be used as a steroid sparing agent in the treatment of poymyalgia rheumatica and giant cell arteritis. Ann Rheum Dis 1996;55:218-223.
36. Chakravarty K, Pountain G, Merry P, Byron M, Iazleman B, Scott DGI. A longitudinal study of anticardiolipin antibody in polymalgia rheumatica and giant cell arteritis. J Rheumatol 1995;22:1694-1697.
37. Salvarani C, Gabriel S, Hunder G. Distal extremity swelling with pitting edema in polymyalgia rheumatica. Arthritis Rheum 1996;39:73-80.
38. Hayreh SS, Podhajsky PA, Zimmerman B. Occular manifestations of giant cell arteritis. Am J Ophthalmol 1998;125:509-520. (Pubitemid 28236919)
39. Spraycar M, Stedman's Medical Dictionary, 26th ed. Baltimore: Williams and Wilkins Publishing Company, 1050.
40. Spraycar M, Stedman's Medical Dictionary, 26th ed. Baltimore: Williams and Wilkins Publishing Company, 647.
41. Spraycar M, Stedman's Medical Dictionary, 26th ed. Baltimore: Williams and Wilkins Publishing Company, 725.
42. Spraycar M, Stedman's Medical Dictionary, 26th ed. Baltimore: Williams and Wilkins Publishing Company, 1402.
43. Spraycar M, Stedman's Medical Dictionary, 26th ed. Baltimore: Williams and Wilkins Publishing Company, 1612.
44. Spraycar M, Stedman's Medical Dictionary, 26th ed. Baltimore: Williams and Wilkins Publishing Company, 1111.
45. Spraycar M, Stedman's Medical Dictionary, 26th ed. Baltimore: Williams and Wilkins Publishing Company, 784, 1179.
46. Wallach J, Interpretation of diagnostic tests. In: Wallach J, ed. Interpretation of Diagnostic Tests. St Louis: Mosby, 1995: 70-90.
47. Hunder G, Vasculitis: diagnosis and therapy. Am J Med 1996;100:37S-46S.
48. Roy FH, The orbit. In: Roy FH. Ocular Differential Diagnosis, 2nd ed. Philadelphia: Lea and Febiger, 1975: 3-38.
49. Beck RW, Cleary PA, Anderson MM, Keltner JL, Shults WT, Kaufman DI et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. New Engl J Med 1992;326:581-588.
50. Lessel S, Corticosteroid treatment of acute optic neuritis. New Engl J Med 1992;326:634-635.
51. Cornblath WT, Eggenberger ER. Progressive visual loss from giant cell arteritis despite high-dose intravenous methylprednisolone. Ophthalmology 1997;104:854-858.
52. Caplanne D, Le Parc JM, Alexandre JA. Interleukin-6 in clinical relapses of polymyalgia rheumatica and giant cell arteritis. Ann Rheum Dis 1996;55:403-404.
53. Richardson MP, Lever AML, Fink AM, Dixon AK, Hazelman BL. Survival after aortic dissection in giant cell arteritis. Ann Rheum Dis 1996;55:1.